Compliance Rate
Compliance Rate
100.0%
Compliant submissions
2
Incompliant submissions
0
Total trials
2
My Organizations' Clinical Trials
Showing 2003 of 2003 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/28/23
End: 12/04/23
Due: 12/04/24
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 06/22/23
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Group-based Integrative Pain Management (IPMP+ Pilot) | NCT05906784 | University of California, San Francisco | user2@example.com | None | 2023-04-28 | 2023-12-04 | 2024-12-04 | - | - | 2025-07-14 |
| Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases | NCT00617539 | University of California, San Francisco | user2@example.com | None | 2005-02-28 | 2014-01-31 | 2015-01-31 | - | - | 2025-07-14 |
| Ocular Rosacea Biome Study | NCT05296837 | University of California, San Francisco | user2@example.com | None | 2023-06-22 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |